Study to evaluate the ovulation inhibitory effect of Minisiston® (0.03 mg Ethinylestradiol and 0.125 mg Levonorgestrel)
Please see attached Study Results Summary below.
No Inclusion Criteria Available
No Exclusion Criteria Available
Monocenter, open-label, uncontrolled study to evaluate the ovulation inhibitory effect of Minisiston® (0.03 mg Ethinyl estradiol and 0.125 mg Levonorgestrel), applied for two treatment cycles to 30 female volunteers